(Adds futures, news items) Britain’s FTSE 100 index is seen opening 5 points lower at 6,286 on Monday, according to financial bookmakers, with futures almost flat ahead of cash markets open.
* GSK: Britain’s GSK said it would invest 130 million pounds ($163.14 million) to buy a 10% stake in Germany’s CureVac.
* STHREE: British recruiting firm SThree Plc said its first-half profit nearly halved, as coronavirus lockdowns slowed hiring globally.
* COVID-19 VACCINE: Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer Inc and BioNTech alliance and French group Valneva.
* OIL: Oil prices fell on Monday, unnerved by the prospect that a recovery in fuel demand could be derailed by a rise in the pace of coronavirus infections around the world.
* GOLD: Gold prices edged lower on Monday due to a stronger U.S. dollar, but worries over surging coronavirus cases and its impact on the global economy kept the safe-haven metal above the psychological level of $1,800 per ounce.
* The UK blue-chip index ended up 0.6% on Friday, bolstered chiefly by AstraZeneca amid anticipation of a deal with Russia to manufacture a COVID-19 vaccine being developed by the drugmaker and Oxford University.
* For more on the factors affecting European stocks, please click on:
> Financial Times
> Other business headlines ($1 = 0.7969 pounds) (Reporting by Samantha Machado and Tapanjana Rudra in Bengaluru; Editing by Krishna Chandra Eluri and Vinay Dwivedi)